The basic science of vascular biology: Implications for the practicing surgeon

Plastic and Reconstructive Surgery

Volumn 126, Issue 5, 2010, Pages 1528-1538

  Glotzbach, Jason P ^a   Levi, Benjamin ^a   Wong, Victor W ^a   Longaker, Michael T ^a   Gurtner, Geoffrey C ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE SCAFFOLD;

ADAPTATION; ANGIOGENESIS; ANIMAL; BLOOD FLOW; BLOOD VESSEL; CELL HYPOXIA; HUMAN; METHODOLOGY; MICROCIRCULATION; MICROVASCULATURE; PHYSIOLOGY; PLASTIC SURGERY; REVIEW; TISSUE ENGINEERING; VASCULARIZATION; WOUND HEALING;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BLOOD VESSELS; CELL HYPOXIA; HUMANS; MICROCIRCULATION; MICROVESSELS; NEOVASCULARIZATION, PHYSIOLOGIC; RECONSTRUCTIVE SURGICAL PROCEDURES; REGIONAL BLOOD FLOW; SURGICAL FLAPS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; WOUND HEALING;

EID: 78650143348     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181ef8ccf     Document Type: Review

References (98)

1. Manchot C. The Cutaneous Arteries of the Human Body. New York: Springer-Verlag; 1983.
2. Conway H, Stark RB, Docktor JP. Vascularization of tubed pedicles. Plast Reconstr Surg. (1946) 1949;4:133-143.
3. Orticochea M. The musculo-cutaneous flap method: An immediate and heroic substitute for the method of delay. Br J Plast Surg. 1972;25:106-110.
4. Ponten B. The fasciocutaneous flap: Its use in soft tissue defects of the lower leg. Br J Plast Surg. 1981;34:215-220.
5. Folkman J, Haudenschild C. Angiogenesis in vitro. Nature 1980;288:551-556.
6. Mathes SJ, Nahai F. Classification of the vascular anatomy of muscles: Experimental and clinical correlation. Plast Reconstr Surg. 1981;67:177-187.
7. Laschke MW, Vollmar B, Menger MD. Inosculation: Connecting the life-sustaining pipelines. Tissue Eng Part B Rev. 2009;15:455-465.
8. Murphy RC, Lawrence WT, Robson MC, Heggers JP. Surgical delay and arachidonic acid metabolites: Evidence for an inflammatory mechanism. An experimental study in rats. Br J Plast Surg. 1985;38:272-277.
9. Park S, Tepper OM, Galiano RD, et al. Selective recruitment of endothelial progenitor cells to ischemic tissues with increased neovascularization. Plast Reconstr Surg. 2004;113:284-293.
10. Morris SF, Taylor GI. The time sequence of the delay phenomenon: When is a surgical delay effective? An experimental study. Plast Reconstr Surg. 1995;95:526-533.
11. Pang CY, Forrest CR, Neligan PC, Lindsay WK. Augmentation of blood flow in delayed random skin flaps in the pig: Effect of length of delay period and angiogenesis. Plast Reconstr Surg. 1986;78:68-74.
12. Jonsson K, Hunt TK, Brennan SS, Mathes SJ. Tissue oxygen measurements in delayed skin flaps: A reconsideration of the mechanisms of the delay phenomenon. Plast Reconstr Surg. 1988;82:328-336.
13. Sano K, Hallock GG, Rice DC. The relative importance of the deep and superficial vascular systems for delay of the transverse rectus abdominis musculocutaneous flap as demonstrated in a rat model. Plast Reconstr Surg. 2002;109:1052- 1057; discussion 1058-1059. (Pubitemid 34206247)
14. Restifo RJ, Syed SA, Ward BA, Scoutt LM, Taylor K. Surgical delay in TRAM flap breast reconstruction: A comparison of 7- and 14-day delay periods. Ann Plast Surg. 1997;38:330-333; discussion 333-334.
15. Atisha D, Alderman AK, Janiga T, Singai B, Wilkins EG. The efficacy of the surgical delay procedure in pedicle TRAM breast reconstruction. Ann Plast Surg. 2009;63:383-388.
16. Taylor GI, Palmer JH. The vascular territories (angiosomes) of the body: Experimental study and clinical applications. Br J Plast Surg. 1987;40:113-141.
17. Callegari PR, Taylor GI, Caddy CM, Minabe T. An anatomic review of the delay phenomenon: I. Experimental studies. Plast Reconstr Surg. 1992;89:397-407; discussion 417-418.
18. Barker JH, Frank J, Bidiwala SB, et al. An animal model to study microcirculatory changes associated with vascular delay. Br J Plast Surg. 1999;52:133-142.
19. Tuttle JL, Nachreiner RD, Bhuller AS, et al. Shear level influences resistance artery remodeling: Wall dimensions, cell density, and eNOS expression. Am J Physiol Heart Circ Physiol. 2001;281:H1380-H1389.
20. van Royen N, Piek JJ, Buschmann I, Hoefer I, Voskuil M, Schaper W. Stimulation of arteriogenesis: A new concept for the treatment of arterial occlusive disease. Cardiovasc Res. 2001;49:543-553. (Pubitemid 32146417)
21. Heil M, Schaper W. Influence of mechanical, cellular, and molecular factors on collateral artery growth (arteriogenesis). Circ Res. 2004;95:449-458.
22. Heil M, Schaper W. Insights into pathways of arteriogenesis. Curr Pharm Biotechnol. 2007;8:35-42.
23. Rey S, Semenza GL. Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc Res. 2010;86:236-242.
24. Lendahl U, Lee KL, Yang H, Poellinger L. Generating specificity and diversity in the transcriptional response to hypoxia. Nat Rev Genet. 2009;10:821-832.
25. Semenza GL. Life with oxygen. Science 2007;318:62-64.
26. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature 2008;453:314-321.
27. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005;438:932-936.
28. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: The scientific foundations of cardiac repair. J Clin Invest. 2005;115:572-583.
29. Ghali S, Butler PE, Tepper OM, Gurtner GC. Vascular delay revisited. Plast Reconstr Surg. 2007;119:1735-1744.
30. Bauer SM, Bauer RJ, Velazquez OC. Angiogenesis, vasculogenesis, and induction of healing in chronic wounds. Vasc Endovasc Surg. 2005;39:293-306.
31. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA. 1995; 92:5510-5514.
32. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol. 1992;12:5447-5454.
33. Kelly BD, Hackett SF, Hirota K, et al. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res. 2003;93:1074-1081.
34. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004;10:858-864.
35. Forsythe JA, Jiang BH, Iyer NV, et al. Activation of vascular endothelial growth factor gene transcription by hypoxiainducible factor 1. Mol Cell Biol. 1996;16:4604-4613.
36. Semenza GL. Perspectives on oxygen sensing. Cell 1999;98: 281-284.
37. Semenza GL. Surviving ischemia: Adaptive responses mediated by hypoxia-inducible factor 1. J Clin Invest. 2000;106: 809-812.
38. Hickey MM, Simon MC. Regulation of angiogenesis by hypoxia and hypoxia-inducible factors. Curr Top Dev Biol. 2006; 76:217-257.
39. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003;3:721-732.
40. Loinard C, Ginouvès A, Vilar J, et al. Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization. Circulation 2009;120:50-59.
41. Weidemann A, Johnson RS. Biology of HIF-1alpha. Cell Death Differ. 2008;15:621-627.
42. Semenza GL. Regulation of oxygen homeostasis by hypoxiainducible factor 1. Physiology (Bethesda) 2009;24:97-106.
43. Folkman J, D'Amore PA. Blood vessel formation: What is its molecular basis? Cell 1996;87:1153-1155.
44. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275:964-967.
45. Folkman J. Tumor angiogenesis: Therapeutic implications. N Engl J Med. 1971;285:1182-1186.
46. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992;267: 10931-10934.
47. Murakami M, Nguyen LT, Zhuang ZW, et al. The FGF system has a key role in regulating vascular integrity. J Clin Invest. 2008;118:3355-3366.
48. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxiainitiated angiogenesis. Nature 1992;359:843-845.
49. Hu G, Xu C, Riordan JF. Human angiogenin is rapidly translocated to the nucleus of human umbilical vein endothelial cells and binds to DNA. J Cell Biochem. 2000;76:452-462.
50. Hudlicka O, Brown MD. Adaptation of skeletal muscle microvasculature to increased or decreased blood flow: Role of shear stress, nitric oxide and vascular endothelial growth factor. J Vasc Res. 2009;46:504-512.
51. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999;85:221-228.
52. Rafii DC, Psaila B, Butler J, Jin DK, Lyden D. Regulation of vasculogenesis by platelet-mediated recruitment of bone marrow-derived cells. Arterioscler Thromb Vasc Biol. 2008;28: 217-222.
53. Velazquez OC. Angiogenesis and vasculogenesis: Inducing the growth of new blood vessels and wound healing by stimulation of bone marrow-derived progenitor cell mobilization and homing. J Vasc Surg. 2007;45(Suppl A):A39-A47.
54. Kopp HG, Ramos CA, Rafii S. Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue. Curr Opin Hematol. 2006;13:175-181.
55. Hattori K, Dias S, Heissig B, et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med. 2001;193:1005-1014.
56. Tepper OM, Capla JM, Galiano RD, et al. Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood 2005;105:1068-1077.
57. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng. 2001;7:211-228.
58. Crisan M, Yap S, Casteilla L, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008;3:301-313.
59. Aicher A, Rentsch M, Sasaki K, et al. Nonbone marrowderived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ Res. 2007; 100:581-589.
60. Jackson KA, Majka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 2001;107:1395-1402.
61. Yi C, Xia W, Zheng Y, et al. Transplantation of endothelial progenitor cells transferred by vascular endothelial growth factor gene for vascular regeneration of ischemic flaps. J Surg Res. 2006;135:100-106.
62. Risau W, Sariola H, Zerwes HG, et al. Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. Development 1988;102:471-478.
63. Shi Q, Rafii S, Wu M, et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998;92:362-367.
64. Kern PA, Knedler A, Eckel RH. Isolation and culture of microvascular endothelium from human adipose tissue. J Clin Invest. 1983;71:1822-1829.
65. Nagano M, Yamashita T, Hamada H, et al. Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood. Blood 2007;110:151-160.
66. Melero-Martin JM, Khan ZA, Picard A, Wu X, Paruchuri S, Bischoff J. In vivo vasculogenic potential of human bloodderived endothelial progenitor cells. Blood 2007;109:4761-4768. (Pubitemid 46827769)
67. Finney MR, Greco NJ, Haynesworth SE, et al. Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia. Biol Blood Marrow Transplant. 2006;12:585-593.
68. Sun N, Panetta NJ, Gupta DM, et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci USA. 2009;106:15720-15725.
69. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676.
70. Taura D, Sone M, Homma K, et al. Induction and isolation of vascular cells from human induced pluripotent stem cells: Brief report. Arterioscler Thromb Vasc Biol. 2009;29:1100-1103.
71. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-867.
72. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002;3:349-363.
73. Zawicki DF, Jain RK, Schmid-Schoenbein GW, Chien S. Dynamics of neovascularization in normal tissue. Microvasc Res. 1981;21:27-47.
74. Jain RK. Molecular regulation of vessel maturation. Nat Med. 2003;9:685-693.
75. Bloch W, Huggel K, Sasaki T, et al. The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing. FASEB J. 2000;14:2373-2376.
76. Altavilla D, Saitta A, Cucinotta D, et al. Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse. Diabetes 2001;50: 667-674.
77. Isner JM. Myocardial gene therapy. Nature 2002;415:234-239.
78. Baumgartner I, Isner J. Stimulation of peripheral angiogenesis by vascular endothelial growth factor (VEGF). Vasa 1998; 27:201-206. (Pubitemid 28525261)
79. Ma D, Ren L, Liu Y, et al. Engineering scaffold-free bone tissue using bone marrow stromal cell sheets. J Orthop Res. 2010;28:697-702.
80. Metcalfe AD, Ferguson MW. Bioengineering skin using mechanisms of regeneration and repair. Biomaterials 2007; 28:5100-5113.
81. Raghunath J, Salacinski HJ, Sales KM, Butler PE, Seifalian AM. Advancing cartilage tissue engineering: The application of stem cell technology. Curr Opin Biotechnol. 2005;16:503-509.
82. Levenberg S, Rouwkema J, Macdonald M, et al. Engineering vascularized skeletal muscle tissue. Nat Biotechnol. 2005;23: 879-884.
83. Brennan MP, Dardik A, Hibino N, et al. Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model. Ann Surg. 2008;248:370-377.
84. Ding F, Humes HD. The bioartificial kidney and bioengineered membranes in acute kidney injury. Nephron Exp Nephrol. 2008; 109:e118-e122.
85. Thorens B. Development and preclinical assessment of a bioartificial pancreas. Swiss Med Wkly. 2007;137(Suppl 155): 68S-71s.
86. Griffith LG, Naughton G. Tissue engineering: Current challenges and expanding opportunities. Science 2002;295:1009-1014.
87. Hutmacher DW. Scaffold design and fabrication technologies for engineering tissues: State of the art and future perspectives. J Biomater Sci Polym Ed. 2001;12:107-124.
88. Hutmacher DW, Schantz T, Zein I, Ng KW, Teoh SH, Tan KC. Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling. J Biomed Mater Res. 2001;55:203-216.
89. Hutmacher DW, Goh JC, Teoh SH. An introduction to biodegradable materials for tissue engineering applications. Ann Acad Med Singapore 2001;30:183-191.
90. Shea LD, Smiley E, Bonadio J, Mooney DJ.DNAdelivery from polymer matrices for tissue engineering. Nat Biotechnol. 1999; 17:551-554.
91. Luo D, Saltzman WM. Synthetic DNA delivery systems. Nat Biotechnol. 2000;18:33-37.
92. Richardson TP, Peters MC, Ennett AB, Mooney DJ. Polymeric system for dual growth factor delivery. Nat Biotechnol. 2001;19:1029-1034.
93. Niklason LE, Gao J, Abbott WM, et al. Functional arteries grown in vitro. Science 1999;284:489-493.
94. Gerecht S, Ferreira LS, Langer R. Vascular differentiation of human embryonic stem cells in bioactive hydrogel-based scaffolds. Methods Mol Biol. 2010;584:333-354.
95. Chang EI, Bonillas RG, El-ftesi S, et al. Tissue engineering using autologous microcirculatory beds as vascularized bioscaffolds. FASEB J. 2009;23:906-915.
96. Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J, Langer R. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA. 2002;99:4391-4396.
97. Yamashita J, Itoh H, Hirashima M, et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000;408:92-96.
98. Yurugi-Kobayashi T, Itoh H, Yamashita J, et al. Effective contribution of transplanted vascular progenitor cells derived from embryonic stem cells to adult neovascularization in proper differentiation stage. Blood 2003;101:2675-2678.